Gene Symbol | IGFBP7 |
---|---|
Entrez Gene | 3490 |
Alt Symbol | AGM, FSTL2, IBP-7, IGFBP-7, IGFBP-7v, IGFBPRP1, MAC25, PSF, RAMSVPS, TAF |
Species | Human |
Gene Type | protein-coding |
Description | insulin-like growth factor binding protein 7 |
Other Description | IGF-binding protein 7|IGFBP-rP1|PGI2-stimulating factor|angiomodulin|insulin-like growth factor-binding protein 7|prostacyclin-stimulating factor|tumor-derived adhesion factor |
Swissprots | B4E1N2 Q53YE6 B7Z9W7 Q9UCA8 Q07822 Q16270 |
Accessions | AAR89912 CAJ21555 EAX05520 EAX05521 Q16270 AF540057 AAN23122 AI761388 AK303915 BAG64844 AK316082 BAH14453 BC017201 AAH17201 BC066339 AAH66339 BT006654 AAP35300 L19182 AAA16187 S75725 AAB32370 NM_001253835 NP_001240764 NM_001553 NP_001544 |
Function | Binds IGF-I and IGF-II with a relatively low affinity. Stimulates prostacyclin (PGI2) production. Stimulates cell adhesion. {ECO:0000269|PubMed:8117260, ECO:0000269|PubMed:8939990}. |
Subcellular Location | Secreted. |
IGFBP7 overexpression lysate - LY419862 from Acris Antibodies
|
||||||||
IGFBP7 293 Cell Lysate - 409305 from ABBIOTEC
|
||||||||
IGFBP-rp1/IGFBP-7 Overexpression Lysate (Native) - NBP2-08191 from Novus Biologicals
|
||||||||
IGFBP7 Over-expression Lysate Product - GWB-48D9C5 from Genway Biotech
|
||||||||
Human IGFBP7 / IBP-7 HEK293 Cell Lysate (WB positive control) - 13100-H08HL-300 from Sino Biological
|
||||||||
Human IGFBP7 / IBP-7 HEK293 Cell Lysate (WB positive control) - 13100-H07HL-300 from Sino Biological
|
||||||||
Human IGFBP7 / IBP-7 HEK293 Cell Lysate (WB positive control) - 13100-H02HL-300 from Sino Biological
|
||||||||
Human IGFBP7 Human Cells Transfected Lysate (positive control) (denatured) - orb173913 from Biorbyt
|
||||||||
Human IGFBP7 Human Cells Transfected Lysate (positive control) (denatured) - orb174016 from Biorbyt
|
||||||||
Human IGFBP7 Human Cells Transfected Lysate (positive control) (denatured) - orb173912 from Biorbyt
|
||||||||
Panoply™ Human IGFBP7 Knockdown Stable Cell Line - CSC-DC007490 from Creative biogene
|